华特达因(000915.SZ)子公司取得一项药品注册证书

Group 1 - The core point of the article is that Huate Dain (000915.SZ) announced that its subsidiary, Shandong Dain Marine Biological Pharmaceutical Co., Ltd. (referred to as Dain Pharmaceutical), has received a drug registration certificate from the National Medical Products Administration for a new medication, Clonidine Hydrochloride Sustained-Release Tablets [1] Group 2 - The drug is intended for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents aged 6 to 17 years, either as a standalone treatment or as an adjunct to central nervous system stimulants [1]